Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.967
-0.063 (-6.11%)
At close: Nov 20, 2024, 4:00 PM
0.988
+0.021 (2.15%)
Pre-market: Nov 21, 2024, 5:06 AM EST
Adicet Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | - | - | 24.99 | 9.73 | 17.9 | 1 | Upgrade
|
| Revenue Growth (YoY) | - | - | 156.83% | -45.65% | 1699.30% | -87.84% | Upgrade
|
| Gross Profit | - | - | 24.99 | 9.73 | 17.9 | 1 | Upgrade
|
| Selling, General & Admin | 27.63 | 26.53 | 26.3 | 22.22 | 15.66 | 8.69 | Upgrade
|
| Research & Development | 100.81 | 106.04 | 71.25 | 47.75 | 33.93 | 23.69 | Upgrade
|
| Operating Expenses | 128.44 | 132.58 | 97.54 | 69.97 | 49.59 | 32.38 | Upgrade
|
| Operating Income | -128.44 | -132.58 | -72.55 | -60.24 | -31.69 | -31.39 | Upgrade
|
| Interest Expense | -0 | -0.03 | -0.08 | -0.18 | -0.13 | - | Upgrade
|
| Interest & Investment Income | 10.83 | 9.98 | 3.76 | 0.09 | 0.79 | 0.94 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.27 | -0.57 | -0.92 | -0.61 | -0.95 | 2.33 | Upgrade
|
| EBT Excluding Unusual Items | -117.88 | -123.2 | -69.79 | -60.93 | -31.99 | -28.12 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -7.1 | - | Upgrade
|
| Impairment of Goodwill | - | -19.46 | - | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | -1.19 | -2.3 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 1.9 | - | Upgrade
|
| Pretax Income | -117.88 | -142.66 | -69.79 | -62.12 | -39.49 | -28.12 | Upgrade
|
| Income Tax Expense | - | - | - | -0.13 | -2.82 | 0.02 | Upgrade
|
| Net Income | -117.88 | -142.66 | -69.79 | -62 | -36.68 | -28.14 | Upgrade
|
| Net Income to Common | -117.88 | -142.66 | -69.79 | -62 | -36.68 | -28.14 | Upgrade
|
| Shares Outstanding (Basic) | 76 | 43 | 41 | 31 | 7 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 76 | 43 | 41 | 31 | 7 | 2 | Upgrade
|
| Shares Change (YoY) | 76.93% | 4.78% | 32.72% | 322.84% | 242.22% | 9.86% | Upgrade
|
| EPS (Basic) | -1.55 | -3.31 | -1.70 | -2.00 | -5.01 | -13.15 | Upgrade
|
| EPS (Diluted) | -1.55 | -3.31 | -1.70 | -2.00 | -5.01 | -13.15 | Upgrade
|
| Free Cash Flow | -92.84 | -98.18 | -61.55 | -64.1 | -42.54 | -28.95 | Upgrade
|
| Free Cash Flow Per Share | -1.22 | -2.28 | -1.50 | -2.07 | -5.81 | -13.54 | Upgrade
|
| Gross Margin | - | - | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | - | - | -290.32% | -619.15% | -177.02% | -3154.57% | Upgrade
|
| Profit Margin | - | - | -279.27% | -637.19% | -204.87% | -2827.94% | Upgrade
|
| Free Cash Flow Margin | - | - | -246.29% | -658.77% | -237.62% | -2909.75% | Upgrade
|
| EBITDA | -121.9 | -126.48 | -69.98 | -58.71 | -30.47 | -30.15 | Upgrade
|
| EBITDA Margin | - | - | -280.02% | - | -170.17% | - | Upgrade
|
| D&A For EBITDA | 6.53 | 6.1 | 2.58 | 1.54 | 1.23 | 1.24 | Upgrade
|
| EBIT | -128.44 | -132.58 | -72.55 | -60.24 | -31.69 | -31.39 | Upgrade
|
| EBIT Margin | - | - | -290.32% | - | -177.01% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.